We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Troponin Blood Test Offers Quick Method for Monitoring Patients After Cardiac Surgery

By HospiMedica International staff writers
Posted on 03 May 2022
Print article
Image: Troponin measurement via blood test a better way to measure risk for heart surgery patients (Photo courtesy of Unsplash)
Image: Troponin measurement via blood test a better way to measure risk for heart surgery patients (Photo courtesy of Unsplash)

Globally about two million adults a year undergo heart surgery and while the procedure prolongs life and improves quality of life, it comes with the risk of serious complications and death. Validating a method with which to predict heart surgery patients most at risk is a big win. A large international study has now identified a first ever marker that is fast and reliable for the monitoring of patients after cardiac surgery.

The study named VISION Cardiac Surgery by researchers at the Population Health Research Institute (PHRI, Hamilton, ON, Canada) has found that the measurement of troponin – a type of protein found in the heart muscle – in patients undergoing heart surgery offers a better way to measure the risk for heart surgery patients. Taken via a simple blood test, troponin was discovered in an earlier study (VISION) to be an effective predictor of risks facing non-cardiac surgery patients. Troponin is not commonly measured after heart surgery, including coronary artery bypass grafting or open-heart surgery such as valve repairs and replacements. As a result, recommendations by medical experts have widely varied (10 to 70 times the lab normal value) regarding troponin levels that define heart attack and one of the most common complications after heart surgery – myocardial injury.

The new study addressing cardiac surgery patients involved 15,984 adult patients (average age just over 63 years) undergoing cardiac surgery. Patients were from 12 countries, more than a third of which were countries outside of North America and Europe. The study team found that by 30 days after heart surgery, 2.1% of patients had died, and 2.9% had experienced a major vascular complication such as heart attack, stroke or life-threatening blot clot.

In the VISION Cardiac Surgery study, “we found that the levels of troponin associated with an increased risk of death within 30 days were substantially higher - 200 to 500 times the normal value - than troponin levels that surgical teams are currently told defines the risk of a patient having myocardial injury,” said PHRI Scientist PJ Devereaux who led the VISION study and was a lead investigator on the new study.

“This study is a landmark for the health teams taking care of patients after cardiac surgery,” added André Lamy, a study investigator, PHRI Scientist and heart surgeon.

“Our findings will help further studies look at the timing of treatments and procedures to improve patient outcomes after heart surgery,” said investigator Richard Whitlock, also a heart surgeon and PHRI Scientist.

Related Links:
PHRI

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Heart-Lung Machine
HL 40

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.